MedPath

MOMSonLINE2 ; A Pilot Study Testing Recruitment and Retention of Women of Color to an Online Support Group for Bereaved Mothers

Not Applicable
Completed
Conditions
Grief
Infant Death
Stillbirth
Interventions
Behavioral: BabyCenter site and the community group
Registration Number
NCT04600076
Lead Sponsor
University of Michigan
Brief Summary

This is a 6-week pilot study to see how research participants feel about an internet support site after a stillbirth or infant death. Losing a baby through stillbirth or early infant death is typically devastating for families. However, investigators do not know if internet on-line support for parents helps manage grief more easily.

In addition to using the BabyCenter.com website, participants will be asked to complete online surveys at the beginning and the end of the study, as well partake in an interview.

Data from this pilot study will help develop a much larger randomized control study of on-line support outcomes after perinatal loss.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
22
Inclusion Criteria
  • Michigan residence and infant delivery
  • Non-Caucasian race and/or Hispanic ethnicity
  • Read/speak English
  • Gave birth to a stillborn baby or had an infant death in the first 28 days of life
  • Did not give the baby up for adoption pre-loss
  • Internet access
Read More
Exclusion Criteria
  • Don't Read/speak English
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
BabyCenter site and the community groupBabyCenter site and the community group-
Primary Outcome Measures
NameTimeMethod
Percentage of Participants Approached for Enrollment Who Signed up for the Study6 months

Feasibility of recruitment as shown by percent of those approached for enrollment who signed up for the study.

Feasibility: Retention6 weeks

Number of participants that completed:

* The 6 week intervention.

* Pre-post surveys.

* Phone interview

Secondary Outcome Measures
NameTimeMethod
Change in Depression as Measured by The Personal Health Questionnaire Depression (PHQ-8)Pre intervention (day 0), Post intervention (6 weeks)

The Personal Health Questionnaire Depression (PHQ-8) is a widely used and validated screen for depression. The PHQ-8 is scored by adding scores from each question (0-3) to a final score (0 to 24). Higher scores indicate worse outcome and a score of 10 or higher indicates a positive screen. A positive screen is probable for clinical depression.

Change in Post-traumatic Stress Disorder (PTSD)Pre intervention (day 0), Post intervention (6 weeks)

PTSD will be measured using the 20-question Post-traumatic stress disorder (PTSD) checklist for the Diagnostic and Statistical Manual of Mental Disorders (DSM) -5 (PTSD Checklist for DSM-5, Civilian Version). Scores range from 0-80. A score of 33 or above will be used as our cutoff. A score above this indicated a probable diagnosis of PTSD.

Change in Anxiety Based on the Generalized Anxiety Disorder Screen (GAD-7)Pre intervention (day 0), Post intervention (6 weeks)

The Generalized Anxiety Disorder screen (GAD-7) is a seven-item self-report instrument for screening, diagnosis and severity assessment of anxiety disorder. The GAD-7 total score for the seven items ranges from 0 to 21: 0-4 Minimal anxiety; 5-9 Mild anxiety; 10-14 Moderate anxiety; 15-21 Severe anxiety.

Change in Grief Based on the Perinatal Grief ScalePre intervention (day 0), Post intervention (6 weeks)

The Perinatal Grief Scale measures grief, coping, and despair following the death of a child. It includes 33 questions on a 5-point Likert scale that ranges from 1=strongly agree to 5=strongly disagree. A higher score would indicate more grief and a lower score less grief. A score cutoff of \>40 to indicates more severe grief. Two questions were inadvertently dropped from the PGS in our surveys; this allows pre-post analysis but limits comparison to other studies. With this omission, our PGS scores could range from 31 -155.

Trial Locations

Locations (1)

University of Michigan

🇺🇸

Ann Arbor, Michigan, United States

© Copyright 2025. All Rights Reserved by MedPath